Intranasal Ketorolac for Acute Pain in Adult Emergency Department Patients
Authors:
- 7 August 2021
- journal article
- research article
- Published by SAGE Publications in Western Journal of Nursing Research
- Vol. 44 (11) , 1047-1056
Abstract
Pain is a common complaint in the emergency department. An alternative to opioids is desirable. Oral medications are not feasible with gastrointestinal disorders or NPO. Intravenous medications require skill and time. Intravenous/intramuscular medications are painful with potential needlestick injury. Intranasal medications have rapid onset, easy administration, do not need skilled providers, and no risk of needlestick injury. A total of 28 adults with acute pain (numeric rating scale ≥ 4) received intranasal ketorolac. Numeric rating scale decreased in all: 32% complete pain relief, median (interquartile range) decrease −5 (−6.8 to −4) (p < .001). Pain relief onset was median [interquartile range] 5 (2.3, 15.0) min. Vital signs remained normal. There were no nasal mucosal changes, no complications. Minor side effects, mostly nasal burning, in 43%, resolved within 5 min. Patients and nurses were satisfied with intranasal ketorolac, and would use it again. Intranasal ketorolac had a rapid onset, was effective, safe, well tolerated with minor side effects that resolved quickly.Keywords
Funding Information
- Luitpold Pharmaceuticals (NA)
This publication has 38 references indexed in Scilit:
- A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid levelCurrent Medical Research and Opinion, 2012
- Intranasal ketorolac tromethamine (SPRIX®) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trialCephalalgia, 2012
- Quantifying Drug-seeking Behavior: A Case Control StudyThe Journal of Emergency Medicine, 2012
- Intranasal ketorolac for acute postoperative painCurrent Medical Research and Opinion, 2010
- Intranasal Ketorolac for Pain Secondary to Third Molar Impaction Surgery: A Randomized, Double-Blind, Placebo-Controlled TrialJournal of Oral and Maxillofacial Surgery, 2010
- Intranasal Ketorolac for Postoperative Pain: A Phase 3, Double-blind, Randomized StudyPain Medicine, 2009
- The Safety and Analgesic Efficacy of Intranasal Ketorolac in Patients with Postoperative PainAnesthesia & Analgesia, 2008
- Pain in the Emergency Department: Results of the Pain and Emergency Medicine Initiative (PEMI) Multicenter StudyThe Journal of Pain, 2007
- Pain and Pain-Related functional interference among discharged emergency department patientsAnnals of Emergency Medicine, 2004
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001